رفتن به محتوا

تداخل‌های دارویی

Alogliptin-pioglitazone + Lonapegsomatropin

شدت: متوسط

Alogliptin-pioglitazone and Lonapegsomatropin: moderate interaction.

آخرین به‌روزرسانی

ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.

محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.

خلاصه

Growth hormone reduces insulin sensitivity, which can raise blood glucose and blunt the effect of alogliptin and pioglitazone. Patients with diabetes may need higher doses of their antihyperglycemic agents.

معنای این تداخل به زبان ساده

Alogliptin-pioglitazone and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Alogliptin-pioglitazone belongs to Endocrine; Lonapegsomatropin belongs to Endocrine.

سطح شواهد: Moderate

چرا رخ می‌دهد

Pharmacodynamic antagonism through growth hormone-induced insulin resistance.

اقدام لازم

Monitor blood glucose and HbA1c when starting or adjusting lonapegsomatropin. Adjust antidiabetic doses as required.

از داروساز چه بپرسید

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

ویژه اعضای Pro+

باز کردن کل صفحه

یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Alogliptin-pioglitazone و Lonapegsomatropin، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.

پرسش‌های متداول

Can I take Alogliptin-pioglitazone with Lonapegsomatropin?

MediHelp rates the interaction as moderate. Alogliptin-pioglitazone and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Growth hormone reduces insulin sensitivity, which can raise blood glucose and blunt the effect of alogliptin and pioglitazone. Patients with diabetes may need higher doses of their antihyperglycemic agents.

How serious is the interaction between Alogliptin-pioglitazone and Lonapegsomatropin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and HbA1c when starting or adjusting lonapegsomatropin. Adjust antidiabetic doses as required.

What other medicines interact with Alogliptin-pioglitazone?

MediHelp also lists interactions of Alogliptin-pioglitazone with, for example, Gemfibrozil, Insulin aspart, Insulin degludec. The full list is on the Alogliptin-pioglitazone page.

تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp

مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.

مرور از A تا Z · تداخل‌های دارویی

دریافت برنامه ورود